Particle.news

Download on the App Store

Biden's Prostate Cancer Diagnosis Sparks Calls for Screening Reform

Experts emphasize advanced treatment options and urge proactive PSA testing following confirmation of Biden's aggressive metastatic prostate cancer.

Image
Image
Image
Image

Overview

  • Joe Biden's office confirmed his diagnosis of Gleason score 9 metastatic prostate cancer with bone metastases, describing treatment as potentially effective.
  • Medical professionals highlight that modern therapies, including hormonal treatment and advanced immunotherapy, can offer hope even in aggressive cases.
  • Biden's last known prostate cancer screening was in 2014, raising concerns about outdated U.S. screening guidelines that discourage routine PSA testing after certain ages.
  • Prostate cancer, often asymptomatic until advanced stages, is the most commonly diagnosed cancer in men in the U.S. and U.K., with one in eight men affected over their lifetime.
  • Leading clinicians are calling for updated screening protocols to catch prostate cancer earlier, emphasizing that early detection significantly improves outcomes.